We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NBR:NYSENabors Industries Ltd. analysis

Data as of Oct 16, 2026 - not real-time

Latest price
$76.39
Risk: medium
6/10Medium risk

Summary

The moving-average structure behind Nabors Industries Ltd. is neutral at $76.39, with no clear ordering between short and long averages. The last 30 days have lost 20.1%. With RSI at 35.7 the momentum picture is approaching oversold, alongside a bearish MACD signal. Price has been bracketed by support at $75.40 and resistance at $86.69.
Multiples put this in undervalued territory: 5.8 times earnings against the sector's 19.0. Sell-side targets cluster 40.6% above the current quote. Revenue is contracting at 2.2% on a 7.7% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 32.4%, a beta of 0.48 and a maximum drawdown of 31.6%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 5 out of 10.

Top market events

  • Second-quarter revenue was USD 816.93 million for the period ended June 30, 2026. Nabors Industries
  • Nabors Industries Ltd. NYSE: NBR invites you to join Anthony G. Petrello, Chairman, President and Chief Executive...
  • Nabors Industries NYSE:NBR Beats Q2 CY2026 Sales Expectations

Market outlook

Short term

< 1 year

Neutral

Model confidence1/101 out of 10

Key factors

  • Trading below the 200-day average of 83.34
  • MACD momentum is negative
  • 30-day price change of -20.1%

Medium term

1–3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • P/E of 5.8 versus sector average of 19.0
  • Trading below the 200-day average of 83.34
  • Analyst targets imply +40.6% versus the current price

Long term

> 3 years

Positive

Model confidence5/105 out of 10

Key factors

  • P/E of 5.8 versus sector average of 19.0
  • Analyst targets imply +40.6% versus the current price
  • Revenue contracting at -2.2%

Key metrics

Financial health

Revenue Growth-2.20%
Profit Margin7.69%
P/E Ratio5.8
ROE22.31%
ROA3.28%
Debt/Equity147.62
P/B Ratio2.1
Op. Cash Flow$702.3M
Free Cash Flow$134.2M
Industry P/E19.0

Technical analysis

TrendNeutral
RSI35.7
Support$75.40
Resistance$86.69
MA 20$80.76
MA 50$86.51
MA 200$83.34
MACDBearish
VolumeDecreasing
Fear & Greed Index92.79

Valuation

Target Price$107.38
Upside/Downside40.56%
GradeUndervalued
TypeBlend

Risk assessment

Beta0.48
Volatility32.43%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.